Kevin L. Mensink, Vice President, Marketing at ENTELLUS MEDICAL INC (ENTL), sold 2,500 shares at $19.00 ($48K) on 2017-10-20, disclosed to the SEC on 2017-10-24.
Scheduled sale ($48k) by Vice President, Marketing under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ENTL | SELL | 2016-08-02 | $143K | — | Filing → |